AGCT1531: A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs.Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors

Go Back to All Clinical Trials

AGCT1531: A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs.Cisplatin for Standard Risk Pediatric and Adult Patients with Germ Cell Tumors

Brief description of study

The purpose of the study is to minimize toxicity by reducing therapy while maintaining current survival rates in the treatment of pediatric, adolescent and young adult patients with standard risk non-seminomatous germ cell tumors. We want to know event-free survival of a carboplatin vs. cisplatin-based regimen and would like to determine if complete surgical resection followed by surveillance can improve overall survival rates.

Clinical Study Identifier: s19-01586

ClinicalTrials.gov Identifier: NCT03067181

Principal Investigator: Sharon L Gardner.

Other Investigators: Ashley Pinchinat, Nicole Mallory, William L Carroll, Jessica Clymer, Kirsty Hillier, Elizabeth A Raetz, Gabriel Andrew Robbins, Elizabeth Ann Roman.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Perlmutter Cancer Center

Clinical Trials & Research Studies